The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts ...
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received ...
This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...
The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on ...
In a surprise move, the FDA has named the longtime leader of its oncology department, Richard Pazdur, M.D., as the new ...
The Food and Drug Administration has appointed Richard Pazdur, the founding director of the agency’s Oncology Center of ...
The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of ...
George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.
Pharmaceutical Technology on MSN
FDA’s revolving door reveals Pazdur as new CDER head
"FDA’s revolving door reveals Pazdur as new CDER head" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback